COVID - 19 Vaccination Update - Day 508 - Prevention is better than cure

Spread the Message

Read Time:1 Minute, 40 Second

Posted On: 07 JUN 2022 8:08PM by PIB Delhi

India’s COVID-19 vaccination coverage has crossed 194.41 Crore (1,94,41,18,069) today. More than 12 lakh (12,86,819) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs	1^st Dose	10407391
	2^nd Dose	10044944
	Precaution Dose	5329993
FLWs	1^st Dose	18420038
	2^nd Dose	17591801
	Precaution Dose	8999957
Age Group 12-14 years	1^st Dose	34661724
	2^nd Dose	18233135
Age Group 15-18 years	1^st Dose	59685883
	2^nd Dose	46458690
Age Group 18-44 years	1^st Dose	557412621
	2^nd Dose	492641714
	Precaution Dose	1225855
Age Group 45-59 years	1^st Dose	203295468
	2^nd Dose	191424443
	Precaution Dose	1632175
Over 60 years	1^st Dose	127126512
	2^nd Dose	119426781
	Precaution Dose	20098944
Cumulative 1^st dose administered		1011009637
Cumulative 2^nd dose administered		895821508
Precaution Dose		37286924
Total		1944118069

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 7^th June, 2022 (508^th Day)
HCWs	1^st Dose	44
	2^nd Dose	520
	Precaution Dose	13082
FLWs	1^st Dose	105
	2^nd Dose	778
	Precaution Dose	32901
Age Group 12-14 years	1^st Dose	95369
	2^nd Dose	243121
Age Group 15-18 years	1^st Dose	33245
	2^nd Dose	102392
Age Group 18-44 years	1^st Dose	35004
	2^nd Dose	351535
	Precaution Dose	55068
Age Group 45-59 years	1^st Dose	5359
	2^nd Dose	74120
	Precaution Dose	40021
Over 60 years	1^st Dose	4310
	2^nd Dose	51904
	Precaution Dose	147941
Cumulative 1^st dose administered		173436
Cumulative 2^nd dose administered		824370
Precaution Dose		289013
Total		1286819

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.